Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
2.100
+0.020 (0.96%)
At close: Jan 16, 2026, 4:00 PM EST
2.120
+0.020 (0.95%)
After-hours: Jan 16, 2026, 4:24 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202001 - 2009
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '10 2001 - 2009
Vision Performance and Health
10.99M
Log In
Log In
Log In
Log In
Upgrade
Vision Performance and Health Growth
-42.30%
Log In
Log In
Log In
Log In
Upgrade
Innovative Treatments
-
Log In
Log In
Log In
Log In
Upgrade
Innovative Treatments Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202001 - 2009
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '10 2001 - 2009
United States
10.99M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-42.30%
Log In
Log In
Log In
Log In
Upgrade